December 9, 2025- At Investor Day, CVS Health will update its 2025 full-year financial guidance, provide 2026 full-year financial guidance and introduce its expectations for a mid-teens Adjusted EPS compound annual growth rate (“CAGR”) over the next three years, driven by unlocking the significant earnings power of its best-in-class businesses:
- strong earnings growth, powered by return to target margins at Aetna®
- winning and retaining business, while delivering attractive margins at CVS Caremark®
- sustaining earnings while serving as the front door to health care at CVS Pharmacy®
- driving towards breakeven with a path to sustained profitability across the Health Care Delivery business
Also, on December 9, at its 2025 Investor Day, CVS Health® will launch its strategy to deliver best-in-class execution, transform consumer experiences, be the partner of choice, and harness unique enterprise capabilities to address challenges across the health care system. With a powerful collection of diversified businesses that work together across the health care landscape – Aetna, CVS Caremark, CVS Pharmacy and Health Care Delivery – CVS Health and its over 300,000 dedicated colleagues can simplify care and improve health in ways no other company can.